Navigation Links
GEOLOGY starts 2013 with 25 new articles posted online ahead of print
Date:1/30/2013

rd University, 20 Oxford Street, Cambridge, Massachusetts 02138, USA. Posted online 17 Jan. 2013; http://dx.doi.org/10.1130/G33783.1.

The largest known strike-slip earthquake of magnitude 8.6 occurred on 11 April 2012 off the northwestern coast of Sumatra. This earthquake ruptured within the Indo-Australian plate, and the slip propagation is shown to be primarily southeast to northwest using seismological and tsunami data. This trend is almost parallel to the nearby trench where the 2004 magnitude 9 Sumatran earthquake occurred. These megathrust events are known to promote subsequent failures within the subducting plate, suggesting that the great earthquake in 2012 is a consequence of the devastating 2004 Sumatran earthquake. Furthermore, this region is characterized by oblique plate convergence, and the trench-parallel component is thought to be taken up by the Great Sumatran Fault on the island of Sumatra. There have been rising concerns that the expected slip from the plate convergence rate is much larger than the observed slip on the Great Sumatran Fault, which has been interpreted as a sign of an impending large earthquake. We propose that the missing slip is mostly accounted for by the magnitude 8.6 earthquake in 2012. If such partitioning of slip between two plates occurs along other oblique subduction zones, the hazard potential of the faults on over-riding plates must be reevaluated.


Eoarchean within-plate basalts from southwest Greenland
F.E. Jenner et al., Dept. of Terrestrial Magnetism, Carnegie Institution of Washington, 5241 Broad Branch Road Northwest, Washington, DC 20015, USA; and Research School of Earth Sciences, The Australian National University, Canberra, ACT 0200, Australia. Posted online 17 Jan. 2013; http://dx.doi.org/10.1130/G33787.1.

Previous geochemical studies have us
'/>"/>

Contact: Kea Giles
kgiles@geosociety.org
303-357-1057
Geological Society of America
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology news :

1. GEOLOGY returns to Naica Cave, Mexico, and extends its reach to Mercury
2. GEOLOGY speeding top science to online platform
3. GEOLOGY adds 30 new articles online
4. Geologys Mystery Interval, the Great Deepening, and the largest kill-off in Earth history
5. Geosphere: How geology, technology, modeling, and mapping see into Earths past and present
6. Sandy beaches, hydrocarbon reservoirs, tectonic tilting: Its all about geology
7. From 503-million-year-old fungi to recent earthquakes: New Geology posted ahead of print
8. Seismic zones, river deltas, landslides, fossil reptiles, and more new Geology science
9. Large, medically important class of proteins starts to yield its secrets
10. Work starts on fossil fuel free cargo ship set to transform shipping industry
11. Lets get moving: Unraveling how locomotion starts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GEOLOGY starts 2013 with 25 new articles posted online ahead of print
(Date:7/24/2014)... 2014) Scientists at The New York Stem ... closer to creating a viable cell replacement therapy ... , For the first time, NYSCF scientists ... skin samples of patients with primary progressive multiple ... to induce these stem cells into becoming oligodendrocytes, ...
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
Breaking Biology News(10 mins):NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2
... Hopkins scientists seems to have discovered an almost-too-easy way to ... potent versions. Their finding, reported this week in Nature, could ... but also other body tissues. What the researchers ... neural stem cells the sort that might be used ...
... The giant panda is not at an evolutionary dead end ... new research involving scientists from Cardiff University. Previous ... requirements and slow reproductive rates have led to a lack ... extinction. Now a study by Professor Michael Bruford ...
... August 23, 2007 On August 16, the Food and ... sold under the brand name Coumadin. The new label suggests ... be safer for patients with variations in two genes, CYP2C9 ... testing, which may be a useful tool in determining appropriate ...
Cached Biology News:When is a stem cell not really a stem cell? 2American College of Medical Genetics responds to new FDA labeling decision for warfarin 2
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
(Date:7/24/2014)...  CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical ... for the prevention and treatment of cardiorenal and ... July 18, 2014 from the NYSE MKT LLC ... plan to regain compliance with continued listing standards ... is continuing the Company,s listing and has granted ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2Getting More Life out of Lithium-ion Batteries 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4
... , , ROCKVILLE, Md., ... has announced that 263 regulatory professionals achieved Regulatory Affairs ... RAC credential is administered by RAPS and is the ... product sector. , , (Logo: ...
... BEIJING, Sept. 4 /PRNewswire-Asia/ -- ... provider of biopharmaceutical products in China, announced today that,the ... Republic,of China has issued the initial order to Sinovac ... to the initial order, Sinovac is,required to complete the ...
... September 4 Karolinska Development (publ),today announced that one ... clinical study of its candidate drug, tafoxiparin, a,new drug ... promising results of the Phase II trial bring the ... strategy. , Dilafor,s candidate drug, ...
Cached Biology Technology:263 Regulatory Professionals Achieve RAC Certification 2263 Regulatory Professionals Achieve RAC Certification 3Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 2Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government 3Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 2Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial 3
Request Info...
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: ... EC 2.7.1.1/1.1.1.49. One unit of ... of D-glucose in 1 min ... One unit of G6P-DH will ...
Request Info...
Biology Products: